VERTEX PHARMACEUTICALS INC / MA - 8-K Filing
Vertex Pharmaceuticals appointed Jonathan Poole as CFO effective January 1, 2027; Charles Wagner will step down from the role but remain COO. (Items: 5.02 Departure of Directors of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of)
Tickers: $VRTX